Management of disseminated midgut carcinoid tumours

H. Ahlman, B. Wangberg, S. Jansson, O. Stenqvist, K. Geterud, Ulf Tylen, K. Caidahl, T. Schersten, L. E. Tisell

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Forty-one patients with disseminated midgut carcinoid tumours were treated over a 6-year period according to a strict programme including primary surgical treatment. In 10 patients, a total remission of the disease was obtained. Patients with bilobar hepatic disease had ischaemic treatment of their liver metastases by hepatic arterial embolisation after primary surgical and medical treatment (low dose octreotide). Thus, by combining surgical, radiological and medical treatment modalities, we wanted to offer these patients optimal palliation. This treatment programme resulted in good symptomatic relief in all patients accompanied by a marked reduction in 5-hydroxyindoleacetic acid (5-HIAA) levels. At recurrence of symptoms in combination with rising 5-HIAA levels, embolisation was repeated. Ten of the treated patients have deceased during the observation period, but only 5 from their carcinoid disease.

Original languageEnglish (US)
Pages (from-to)78-96
Number of pages19
Issue number2
StatePublished - 1991
Externally publishedYes


  • Carcinoid tumours
  • Embolisation for carcinoid tumours
  • Midgut carcinoid tumours
  • Octreotide

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Management of disseminated midgut carcinoid tumours'. Together they form a unique fingerprint.

Cite this